Halozyme Therapeutics, Inc.
HALO Real Time Price USDRecent trades of HALO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by HALO's directors and management
Government lobbying spending instances
-
$60,000 Oct 17, 2024 Issue: Health Issues
-
$60,000 Jul 12, 2024 Issue: Health Issues
-
$60,000 Apr 14, 2024 Issue: Health Issues
-
$60,000 Oct 17, 2023 Issue: Medicare/Medicaid
-
$20,000 Jul 16, 2023 Issue: Medicare/Medicaid
-
$30,000 Apr 19, 2020 Issue: Science/Technology Health Issues Medicare/Medicaid
-
$30,000 Jan 19, 2020 Issue: Medicare/Medicaid Science/Technology Health Issues
-
$20,000 Oct 20, 2019 Issue: Medicare/Medicaid Science/Technology Health Issues
-
$20,000 Aug 08, 2006 Issue: Health Issues Pharmacy
-
$20,000 Feb 14, 2006 Issue: Health Issues Pharmacy
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of HALO in WallStreetBets Daily Discussion
Recent insights relating to HALO
Recent picks made for HALO stock on CNBC
ETFs with the largest estimated holdings in HALO
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view HALO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.